Sai Life Sciences IPO GMP: Subscription BEGINS

Sai Life Sciences, supported by TPG Capital, raised Rs 913 crore from anchor investors prior to its IPO launch. The Rs ...
The promoters and promoter group hold an aggregate of 41.82% of the pre-offer issued and paid-up equity share capital. Their post-IPO shareholding is expected to be around 35.24%.